An Open-label, Fixed-sequence Drug-drug Interaction Study in Healthy Subjects to Evaluate the Effect of GLPG4716 on the Pharmacokinetics of Nintedanib and Pirfenidone
Latest Information Update: 07 Jun 2022
At a glance
- Drugs Nintedanib (Primary) ; OATD-01 (Primary) ; Pirfenidone (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Interstitial lung diseases; Non-alcoholic steatohepatitis
- Focus Pharmacokinetics
- Sponsors Galapagos NV
- 01 Jun 2022 Status changed from recruiting to completed.
- 29 Oct 2021 Planned End Date changed from 1 Oct 2021 to 1 Jun 2022.
- 29 Oct 2021 Planned primary completion date changed from 1 Oct 2021 to 1 Jun 2022.